Etcembly
Immunotherapy company Etcembly joins AI firms at The Oxford Science Park
The machine learning immunotherapy discovery company joins a group of thriving companies which use artificial intelligence techniques in their research.
The machine learning immunotherapy discovery company joins a group of thriving companies which use artificial intelligence techniques in their research.